期刊文献+

牛朊蛋白理化性质分析及其多克隆抗体的制备

Physico-Chemical Property and Polyclonal Antibody Production of Bovine Prion Protein
原文传递
导出
摘要 目的:研究酸诱导牛正常细胞朊蛋白(BoPrPC)变性过程中间体的结构,同时制备其多克隆抗体。方法:表达纯化蛋白质后通过荧光光谱法和圆二色法分析酸性条件下BoPrPC二级结构变化。同时制备多克隆抗体,通过ELISA测定多克隆抗体效价,Western blot测定其特异性。结果:酸诱导BoPrPC去折叠并在pH 4.0条件下形成去折叠中间体,易于形成淀粉样纤维聚集体。制备的多克隆抗体效价可达到1∶6 400,能特异性结合朊蛋白。结论:折叠中间体二级结构类似致病BoPrPSc能形成淀粉样纤维聚集体,成功地制备了效价及特异性良好的兔抗BoPrPC多克隆抗体,为研究阻断致病朊蛋白形成淀粉纤维聚集体防治神经细胞损伤以及临床特异性检测奠定基础。 Objective: To study the intermediate structure of denatured bovine prion protein(BoPrPC) induced by acid,and to prepare and identify its polyclonal antibody.Methods: The recombinant bovine mature prion protein(BoPrPC) has been expressed and purified.Fluorescence spectroscopy and circular dichroism were used to study the structure change of BoPrPC induced by acid.BoPrPC was used to immune the rabbit for preparing polyclonal antibody.The titer and specificity of the rabbit's antiserum was measured by ELISA and Western blotting.Results: BoPrPC was unfolded induced by acid,and the intermediate was at about pH 4.0 and prone to form amyloid.The polyclonal antibody was also successfully prepared after immunizing the rabbit.The titer of the antiserum measured by ELISA could achieve 1∶6 400.The specificity of antibody was proved by Western blotting analysis.Conclusion: The structure of unfolding intermediate was similar to pathogenic BoPrPSc and would form amyloid aggregates.The BoPrPC L polycl...更多onal antibody with high titer and specificity can satisfy the request of Western blot and immunohistochemistry experiment,and laid a foundation to study the characters and function of BoPrPCL.
出处 《武汉大学学报(医学版)》 CAS 北大核心 2009年第5期628-632,共5页 Medical Journal of Wuhan University
基金 教育部"长江学者和创新团队发展计划"(编号:IRT0745) 国家自然科学基金资助项目(编号:30770421) 973计划(编号:2006CB910301)
关键词 牛正常细胞朊蛋白 致病朊蛋白 酸变性 多克隆抗体 Cell Bovine Prion Protein Pathogenic BoPrPSc Acid Polyclonal Antibody
  • 相关文献

参考文献10

  • 1Torrent J, Alvarez-Martinez MT, Harricane MC, et al. High pressure induces serapie-like prion protein misfolding and amyloid fibril formation [J]. Biochemistry, 2004, 43(22): 7 162-7 170.
  • 2Prusiner S B. Shattuck lecture neurodegenerative diseases and prions[J]. N Engl J Med, 2001, 344(20):1 516-1 526.
  • 3Noinville S, Chich JF, Rezaei H. Misfolding of the prion protein: linking biophysical and biological approaches[J]. Vet Res, 2008, 39(4): 48-65.
  • 4WANG Dawei,YANG Huaiyi,RAO Zihe,TIAN Bo.High-level expression and secondary structure analysis of the bovine mature prion protein[J].Chinese Science Bulletin,2000,45(14):1312-1315. 被引量:3
  • 5Thomzig A, Spassov S, Friedrich M, et al. Discriminating scrapie and bovine spongiform encephalopathy isolates by infrared spectroscopy of pathological prion protein[J]. J Biol Chem, 2004, 279(32): 33 847- 33 854.
  • 6Baskakov IV, Legname G, Baldwin MA, et al. Pathway complexity of prion protein assembly into amyloid [J]. J Biol Chem, 2002, 277(24): 21 140-21 148.
  • 7Morillas M, Vanik DL, Surewicz WK. On the mechanism of alpha-helix to beta-sheet transition in the recombinant prion protein[J]. Biochemistry, 2001, 40 (23): 6 982-6 987.
  • 8Calzolai L, Zahn R. Influence of pH on NMR structure and stability of the human prion protein globular domain [J]. J Biol Chem, 2003, 278 (37): 35 592- 35 596.
  • 9Martins SM, Chapeaurouge A, Ferreira ST. Folding intermediates of the prion protein stabilized by hydrostatic pressure and low temperature [J]. J Biol Chem, 2003, 278(50): 50 449-50 455.
  • 10Tatzelt J, Winklhofer KF. Folding and misfolding of the prion protein in the secretory pathway [J]. Amyloid, 2004, 11(3): 162-172.

二级参考文献1

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部